Age at menopause was linked to some blood markers of brain damage decades later
In 893 US women aged 65 and older, those whose menopause came later had lower levels of two blood markers tied to dementia, about 25 years after the change. Other markers showed no clear link, one went the unexpected way, and the study is observational and not yet peer-reviewed.
About two-thirds of people living with Alzheimer's disease are women, and researchers keep asking whether menopause plays a part. Studies have found that women whose menopause comes early have a somewhat higher risk of dementia later in life. What has been missing is a look at what happens in the brain biology of these women, in a large group that resembles the general population.
This new study, posted as a preprint (not yet peer-reviewed), measured several blood markers of brain damage in older American women. Later menopause went with lower levels of two of these markers, but the pattern was patchy: some markers showed nothing, and one moved in the unexpected direction.
Blood tests for brain damage
In recent years it has become possible to detect signs of brain disease in a blood sample. This study looked at four main markers:
- NfL (neurofilament light), a piece of the inner skeleton of nerve fibres that leaks into the blood when nerve cells are damaged, whatever the cause;
- GFAP, a protein from astrocytes, support cells in the brain that become activated when the brain is under stress;
- p-tau181, a form of tau, the protein that clumps inside nerve cells in Alzheimer's disease;
- GDF-15, a stress signal released by many tissues and linked to inflammation and aging in general, not specifically to Alzheimer's.
It also checked the ratio of two forms of amyloid, the protein that forms plaques in Alzheimer's, though the authors note this blood test is fairly imprecise.
What they did
The Health and Retirement Study regularly interviews a nationally representative sample of Americans aged 50 and over. In 2016, participants were invited to give a blood sample at home, and dementia markers were later measured in a random subset. The team analysed 893 women aged 65 or older who had reached menopause naturally (on average at age 50) and had not had a hysterectomy, an operation to remove the womb. At the blood draw they were 75 years old on average, roughly 25 years past menopause.
What they found
- NfL followed a curve. Women who reached menopause in their mid-to-late 40s had the highest levels; from age 50 onwards, each year of later menopause went with lower NfL. Between menopause at 45 and 50 there was no clear trend.
- GDF-15 was lower with later menopause, in a straight-line pattern: the later the menopause, the lower the level.
- GFAP and p-tau181 showed no statistically significant link, although their patterns pointed in the same direction as NfL.
- The amyloid ratio went the unexpected way: later menopause was linked to a lower ratio, which usually signals more amyloid. The authors call this unexpected and urge caution because of the test's imprecision.
- Hysterectomy (in a wider group of 1,449 women) was linked to higher GDF-15 only.
- The APOE4 gene, the strongest common genetic risk factor for Alzheimer's, did not significantly change the results, although links looked somewhat stronger in carriers.
- The results held after adjusting for diabetes, high blood pressure, obesity and kidney function.
What to keep in mind
- Not yet peer-reviewed, and observational: it shows associations, not that early menopause damages the brain. The authors also raise the idea that menopause timing may simply reflect a deeper biological "clock" that drives both reproductive and brain aging.
- The effects are small, measured in fractions of a standard deviation per year of menopause age, and only two of the four main markers showed a clear link. The authors suggest that limited statistical power and the imprecision of blood tests may explain the null results.
- Age at menopause was recalled years later. The team used each woman's first report, and repeated reports agreed fairly well.
- No data on hormone use. The survey did not ask about birth-control pills or menopausal hormone therapy, nor whether the ovaries were removed during a hysterectomy, so confounding is possible.
- Blood markers are not a diagnosis. NfL in particular rises with nerve damage of many kinds, not only with Alzheimer's. When the results were weighted to represent the whole US population, they pointed the same way but were weaker and less precise.
Why it matters
This is one of the first looks at menopause timing and blood markers of brain damage in a nationally representative group. It fits with earlier work on this site linking menopause to blood proteins and brain aging and early menopause to older-looking DNA marks. The authors suggest that some of the differences they found reflect general stress and blood-vessel processes rather than Alzheimer's specifically. They call for replication in other large studies with fuller records of women's reproductive health, including hormone therapy and surgery.